{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T18:10:34Z","timestamp":1765303834195,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.prp.2022.154033","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T22:17:05Z","timestamp":1658182625000},"page":"154033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association of ATG16L1 rs2241880 and TP53 rs1042522 with characteristics and course of diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"237","author":[{"given":"An\u0111elina","family":"\u017divanovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragana","family":"Stamatovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nata\u0161a","family":"Streli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvonko","family":"Magi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivera","family":"Tarabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivera","family":"Miljanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Mi\u0161ovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"\u0110uki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojana","family":"Cikota-Aleksi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.154033_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.154033_bib2","doi-asserted-by":"crossref","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","article-title":"ESMO Guidelines Committee, diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2022.154033_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fonc.2019.00107","article-title":"Dysregulation of cell survival in diffuse large B cell lymphoma: mechanisms and therapeutic targets","volume":"9","author":"Miao","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2022.154033_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.154033_bib5","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.154033_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.154033_bib7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.prp.2022.154033_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cells8020103","article-title":"Therapeutic modulation of autophagy in leukaemia and lymphoma","volume":"8","author":"Djavaheri-Mergny","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2022.154033_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-019-0474-7","article-title":"Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients","volume":"27","author":"Mulcahy Levy","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2022.154033_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10555-018-9727-z","article-title":"Pro-survival autophagy and cancer cell resistance to therapy","volume":"37","author":"Das","year":"2018","journal-title":"Cancer Metastas. Rev."},{"key":"10.1016\/j.prp.2022.154033_bib11","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1073\/pnas.1407001111","article-title":"Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense","volume":"111","author":"Lassen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2022.154033_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nature13044","article-title":"A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3","volume":"506","author":"Murthy","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.154033_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biom8020014","article-title":"p53-mediated molecular control of autophagy in tumor cells","volume":"8","author":"Mrakovcic","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2022.154033_bib14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/ijc.30838","article-title":"German high-grade non-hodgkin lymphoma study group (DSHNHL), TP53 mutation and survival in aggressive B cell lymphoma","volume":"141","author":"Zenz","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2022.154033_bib15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/aje\/kws394","article-title":"Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer","volume":"177","author":"Dahabreh","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.prp.2022.154033_bib16","unstructured":"\u3008https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs2241880#frequency_tab\u3009 (accessed 2021\/12\/29)."},{"key":"10.1016\/j.prp.2022.154033_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5562\/cca1866","article-title":"The Arg72Pro polymorphism of TP53 in croatian population","volume":"85","author":"Zoric","year":"2012","journal-title":"Croat. Chem. Acta"},{"key":"10.1016\/j.prp.2022.154033_bib18","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.3390\/ijms21218196","article-title":"Pathogenic single nucleotide polymorphisms on autophagy-related genes","volume":"21","author":"Tamargo-G\u00f3mez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2022.154033_bib19","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1002\/cam4.929","article-title":"GEM Study Group, Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study","volume":"5","author":"White","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2022.154033_bib20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/gutjnl-2014-308735","article-title":"The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon","volume":"65","author":"Grimm","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.prp.2022.154033_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12935-018-0609-9","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis","volume":"18","author":"Mu","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2022.154033_bib22","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2147\/CMAR.S245928","article-title":"The neutrophil to lymphocyte and lymphocyte to monocyte ratios as new prognostic factors in hematological malignancies -a narrative review","volume":"12","author":"Stefaniuk","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.prp.2022.154033_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hon.2757","article-title":"Improving the international prognostic index score using peripheral blood counts: results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma","volume":"38","author":"Marcheselli","year":"2020","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.prp.2022.154033_bib24","doi-asserted-by":"crossref","first-page":"19556","DOI":"10.18632\/oncotarget.14700","article-title":"Peripheral blood lymphocyte to monocyte ratio recovery from low levels at diagnosis after completion of first line therapy predicts good clinical outcomes in patients with diffuse large B-cell lymphoma","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2022.154033_bib25","article-title":"Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP","volume":"95","author":"Wang","year":"2016","journal-title":"Med. (Baltim.)"},{"key":"10.1016\/j.prp.2022.154033_bib26","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.7150\/jca.50552","article-title":"Prognostic value of peripheral blood lymphocyte\/monocyte ratio in lymphoma","volume":"12","author":"Gao","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2022.154033_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkz001","article-title":"Autophagy-mediated regulation of neutrophils and clinical applications","volume":"8","author":"Yu","year":"2020","journal-title":"Burns Trauma"},{"key":"10.1016\/j.prp.2022.154033_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12943-019-0944-z","article-title":"The relationship between autophagy and the immune system and its applications for tumor immunotherapy","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2022.154033_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.603661","article-title":"The role of autophagy in tumor immunology-complex mechanisms that may be explored therapeutically","volume":"10","author":"de Souza","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2022.154033_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12964-021-00769-0","article-title":"Role of autophagy on cancer immune escape","volume":"19","author":"Duan","year":"2021","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.prp.2022.154033_bib31","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.molonc.2016.08.005","article-title":"Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation","volume":"10","author":"Zarogoulidis","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2022.154033_bib32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/15548627.2017.1308997","article-title":"The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer","volume":"13","author":"Li","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.prp.2022.154033_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.radonc.2016.02.028","article-title":"To live or let die: Unclear task of autophagy in the radiosensitization battle","volume":"119","author":"Ondrej","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.prp.2022.154033_bib34","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00432-017-2487-2","article-title":"Role of autophagy in regulating the radiosensitivity of tumor cells","volume":"143","author":"Xin","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.154033_bib35","article-title":"Potentially functional variants of autophagy-related genes are associated with the efficacy and toxicity of radiotherapy in patients with nasopharyngeal carcinoma","volume":"7","author":"Yang","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.prp.2022.154033_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10689-013-9690-3","article-title":"RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women","volume":"13","author":"Krivokuca","year":"2014","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.prp.2022.154033_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/jclinpath-2018-205553","article-title":"TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool","volume":"72","author":"Cavic","year":"2019","journal-title":"J. Clin. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:52:16Z","timestamp":1759733536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822002771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":37,"alternative-id":["S0344033822002771"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154033","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of ATG16L1 rs2241880 and TP53 rs1042522 with characteristics and course of diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154033"}}